Apremilast in Patients With Moderate to Severe Plaque Psoriasis of the Scalp
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The British Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Apremilast in Patients With Moderate-to-Severe Plaque Psoriasis of the Scalp: Results up to 32 Weeks From a Randomized, Phase III Study
Br J Dermatol 2021 Mar 24;[EPub Ahead of Print], AS Van Voorhees, L Stein Gold, M Lebwohl, B Strober, H Sofen, K Papp, J Bagel, Z Zhang, M Paris, Y WangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.